Genetic Variants in the 3’UTR of BRCA1 and BRCA2 Genes and Their Putative Effects on the microRNA Mechanism in Hereditary Breast and Ovarian Cancer

Autor: Idalia Garza-Veloz, María Marisela Sánchez-Chaparro, Omar Alejandro Zayas-Villanueva, Diana Reséndez-Pérez, Margarita L Martinez-Fierro, Laura Elia Martínez-de-Villarreal, Iram P. Rodriguez-Sanchez, Mayra A. Gómez-Govea, Ivan Delgado-Enciso
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Diagnostics
Diagnostics, Vol 10, Iss 298, p 298 (2020)
Volume 10
Issue 5
ISSN: 2075-4418
Popis: Hereditary breast and ovarian cancer (HBOC) syndrome is mainly caused by mutations in the BRCA1 and BRCA2 genes. The 3&rsquo
UTR region allows for the binding of microRNAs, which are involved in genetic tune regulation. We aimed to identify allelic variants on 3&rsquo
UTR miRNA-binding sites in the BRCA1 and BRCA2 genes in HBOC patients. Blood samples were obtained from 50 patients with HBOC and from 50 controls. The 3&rsquo
UTR regions of BRCA1 and BRCA2 were amplified by PCR and sequenced to identify genetic variants using bioinformatics tools. We detected nine polymorphisms in 3&rsquo
UTR, namely: four in BRCA1 (rs3092995 (C/G), rs8176318 (C/T), rs111791349 (G/A), and rs12516 (C/T)) and five in BRCA2 (rs15869 (A/C), rs7334543 (A/G), rs1157836 (A/G), and rs75353978 (TT/del TT)). A new variant in position c.*457 (A/C) on 3&rsquo
UTR of BRCA2 was also identified. The following three variants increased the risk of HBOC in the study population: rs111791349-A, rs15869-C, and c.*457-C (odds ratio (OR) range 3.7&ndash
15.4
p <
0.05). Genetic variants into the 3&rsquo
UTR of BRCA1 and BRCA2 increased the risk of HBOC between 3.7&ndash
15.4 times in the study population. The presence/absence of these polymorphisms may influence the loss/creation of miRNA binding sites, such as hsa-miR-1248 in BRCA1 3&prime
UTR or the hsa-miR-548 family binding site in BRCA2. Our results add new evidence of miRNA participation in the pathogenesis of HBOC.
Databáze: OpenAIRE